Clarifying breast cancer risks associated with menopausal hormone therapy
Lancet Oncol
.
2006 Nov;7(11):885-6.
doi: 10.1016/S1470-2045(06)70915-9.
Authors
Montserrat Garcia-Closas
,
Mark E Sherman
,
Louise A Brinton
PMID:
17081912
DOI:
10.1016/S1470-2045(06)70915-9
No abstract available
Publication types
Comment
Letter
Review
MeSH terms
Breast Neoplasms / chemically induced*
Clinical Trials as Topic
Estrogen Replacement Therapy / adverse effects*
Female
Humans
Menopause*
Middle Aged
Risk Factors